Several studies have demonstrated that phosphorothioate and 2′-O-methoxyethyl- modified ASOs targeting the splicing cis element called ISS-N1 increase SMN2 exon 7 inclusion, thus increasing levels of SMN protein, alleviating the symptoms in patients with spinal muscular atrophy [152]. The gene discussed is SMN2; the disease is spinal muscular atrophy.